Specialty Pharmacy News – Drug Store News #barr #pharma

Posted On Apr 20 2017 by

#pharmacy news # Specialty Pharmacy News Two recent unanimous approval recommendations from FDA advisory committees regarding biosimilars is a signal of growing scientific acceptance and understanding of the biosimilar regulatory pathway, suggested The National Law Review in a report Tuesday. The National Law Review has created a chart summarizing pending and approved BLAs for biosimilars using publicly available information, the publication noted, but there are still two barriers to entry. As biosimilars gain FDA approval, patent issues remain a barrier and the exorbitant R D cost prevent significant price disparities. Accordingly, insurers may be slow to add biosimilars to the …


Irish Pharmacy News #aai #pharma

Posted On Apr 20 2017 by

#pharmacy news # Welcome to IPN Communications Welcome to IPN Communications Ltd. an Irish based publishing company specialising in the Pharmacy sector of Ireland. Armed with the premier, most exciting pharmacy trade magazine in the country Irish Pharmacy News (IPN), the recently launched Hospital Pharmacy News (HPN), the yearly Irish Pharmacy Awards, the Pride in Product Awards and CPD we are constantly innovating and bringing you the best opportunity to understand how to improve your business. Quick Links Contact Us DUBLIN OFFICE Office 36 Clifton House Lower Fitzwilliam Street Dublin 2 Recent News A few months removed from the 2016 …


Humanwell and PuraCap to acquire Epic Pharma for $550m – Pharmaceutical Technology #zuellig #pharma

Posted On Apr 20 2017 by

#epic pharma # Humanwell and PuraCap to acquire Epic Pharma for $550m Humanwell Healthcare Group and PuraCap Pharmaceutical have agreed to acquire US-based Epic Pharma in a deal valued at $550m. With this investment, Humanwell and PuraCap will expand their presence in the US generics market and existing commercial and manufacturing capabilities. The deal includes Epic’s generic product portfolio which includes tablets, two-piece capsules and powder dosage form products, as well as a future product portfolio that will include a series of controlled drug substances. Epic’s portfolio consists of 15 marketed generic products and a pipeline of 37 products. The …


Humanwell Healthcare, PuraCap Acquire Epic Pharma – Contract Pharma #mds #pharma #services

Posted On Apr 20 2017 by

#epic pharma # Related Breaking News Humanwell Healthcare Group and PuraCap Pharmaceutical have acquired Epic Pharma for $550 million. The acquisition will further establish Humanwell and PuraCap in the U.S. generics market and expand their existing commercial and manufacturing capabilities. The acquisition of Epic will provide a robust generic product portfolio, which includes tablets, 2-piece capsules and powder dosage form products as well as a future product portfolio that will include a series of controlled drug substances. Humanwell and PuraCap will acquire Epic s balanced and diversified portfolio, which currently consists of 15 marketed generic products and a pipeline of …


Evaluating Pharmaceutical Companies #contract #pharmaceutical #manufacturing

Posted On Apr 20 2017 by

#small pharma companies # Evaluating Pharmaceutical Companies When Viagra surged into consumers’ bedrooms, Pfizer’s stock enjoyed a sudden rise – satisfying investors and consumers alike. Although Pfizer was far from an unknown company at the time, most of us did not hold stock. There are many reasons why an investor may not feel comfortable investing in pharmaceutical companies, but if you do want to get in on the next little blue pill there is still the obstacle of how to evaluate the industry. This article will explore some of the issues involved in pharmaceutical investing. What’s the Pipeline and Why …


Humanwell Healthcare Group and PuraCap Pharmaceutical LLC to Acquire Epic Pharma, LLC #pharmaceutical #industry #growth

Posted On Apr 20 2017 by

#epic pharma # Humanwell Healthcare Group and PuraCap Pharmaceutical LLC to Acquire Epic Pharma, LLC The acquisition of Epic will provide a robust generic product portfolio which includes tablets, 2-piece capsules and powder dosage form products as well as a future product portfolio that will include a series of controlled drug substances. Humanwell and PuraCap will acquire Epic’s balanced and diversified portfolio, which currently consists of 15 marketed generic products and a pipeline of 37 products, and this acquisition will complement PuraCap’s own R D efforts by utilizing Epic’s strengths in the manufacture and development of controlled drug substances and …


Novartis – sales performance, data and rankings – Top Pharma List #pharma #packaging

Posted On Apr 20 2017 by

#pharma company # Novartis Data by GlobalData GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value. To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com Featured jobs Director, Scientific Services Great salary and benefits ID Search Selection Principal Medical Writer Great salary and benefits ID Search Selection Director, Scientific Services 80 – …


Epic Pharma LLC Company Information #pharmaceutical #job

Posted On Apr 20 2017 by

#epic pharma # Epic Pharma LLC Humanwell Healthcare Group and PuraCap Pharmaceutical agreed to acquire Epic Pharma in March 2016. Drugs Associated with Epic Pharma LLC (aquired by PuraCap Pharmaceutical) Epic Pharma LLC (aquired by PuraCap Pharmaceutical) manufactures, markets and/or distributes more than 19 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page. Average User Rating Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily …


Pharmaceutical Software #european #pharmaceutical #companies

Posted On Apr 20 2017 by

#pharma software # Pharmaceutical Software Pharmaceutical Software challenges are unique The pharmaceutical market is worth around US$980 billion per year, and continues to steadily rise. We understand these continuous changes and the regulations associated with the pharmaceutical industry, and have devised a system that will help you gain insight into your daily pharmaceutical operations without sacrificing a solid financial reporting foundation. Industry-standard functionality Pharmaceutical Software can handle all of the special manufacturing, distribution, and accounting needs of the pharmaceutical industry, including: Automatically prepare State control documents, such as the Pedigree Report required by some states that shows the full history …


ISIS Pharma Consulting #market #research #pharmaceutical

Posted On Apr 20 2017 by

#pharma consulting # Interim Management. Senior Interim QA and Regulatory Affairs roles undertaken. continue reading Quality. Quality Assurance Consultation continue reading Regulatory Affairs. Regulatory Affairs Consultation, Conducting Regulatory Due Diligence audits, Preparation of Expert Reports continue reading Medical Devices. Provision of QA, Gaining Quality system accreditation eg ISO 9001 continue reading Welcome to ISIS Pharma Consulting Isis Pharma Consulting offers a unique combination of Quality Assurance and Regulatory Affairs expertise, supported by considerable senior management experience. We offer interim management and bespoke consultancy services. The company is headed by Indira Walker who is ably assisted by a team of associates. …